Annual Operating Expenses
$57.48 M
-$21.49 M-27.21%
June 30, 2024
Summary
- As of February 8, 2025, AYTU annual total operating expenses is $57.48 million, with the most recent change of -$21.49 million (-27.21%) on June 30, 2024.
- During the last 3 years, AYTU annual operating expenses has fallen by -$9.96 million (-14.78%).
- AYTU annual operating expenses is now -34.97% below its all-time high of $88.39 million, reached on June 30, 2022.
Performance
AYTU Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$12.13 M
-$1.30 M-9.71%
September 30, 2024
Summary
- As of February 8, 2025, AYTU quarterly total operating expenses is $12.13 million, with the most recent change of -$1.30 million (-9.71%) on September 30, 2024.
- Over the past year, AYTU quarterly operating expenses has dropped by -$1.77 million (-12.76%).
- AYTU quarterly operating expenses is now -54.65% below its all-time high of $26.75 million, reached on June 30, 2021.
Performance
AYTU Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AYTU Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -27.2% | -12.8% |
| 3 y3 years | -14.8% | -41.4% |
| 5 y5 years | +161.7% | -16.8% |
AYTU Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -35.0% | at low | -48.6% | at low |
| 5 y | 5-year | -35.0% | +161.7% | -54.6% | +61.0% |
| alltime | all time | -35.0% | >+9999.0% | -54.6% | >+9999.0% |
Aytu BioPharma Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $12.13 M(-9.7%) |
| Jun 2024 | $57.48 M(-27.2%) | $13.44 M(-3.4%) |
| Mar 2024 | - | $13.91 M(+0.5%) |
| Dec 2023 | - | $13.84 M(-0.5%) |
| Sep 2023 | - | $13.90 M(-11.7%) |
| Jun 2023 | $78.96 M(-10.7%) | $15.76 M(-28.5%) |
| Mar 2023 | - | $22.04 M(+2.6%) |
| Dec 2022 | - | $21.49 M(+9.1%) |
| Sep 2022 | - | $19.68 M(-10.3%) |
| Jun 2022 | $88.39 M(+31.1%) | $21.95 M(-0.9%) |
| Mar 2022 | - | $22.14 M(-6.1%) |
| Dec 2021 | - | $23.59 M(+14.0%) |
| Sep 2021 | - | $20.70 M(-22.6%) |
| Jun 2021 | $67.44 M(+80.9%) | $26.75 M(+83.6%) |
| Mar 2021 | - | $14.57 M(+10.7%) |
| Dec 2020 | - | $13.16 M(+1.1%) |
| Sep 2020 | - | $13.01 M(-11.2%) |
| Jun 2020 | $37.27 M(+69.7%) | $14.65 M(+37.7%) |
| Mar 2020 | - | $10.64 M(+41.2%) |
| Dec 2019 | - | $7.54 M(+29.9%) |
| Sep 2019 | - | $5.80 M(+2.7%) |
| Jun 2019 | $21.96 M(+12.9%) | $5.65 M(-6.8%) |
| Mar 2019 | - | $6.06 M(+4.1%) |
| Dec 2018 | - | $5.82 M(+31.2%) |
| Sep 2018 | - | $4.44 M(-1.6%) |
| Jun 2018 | $19.45 M(-5.9%) | $4.51 M(-12.2%) |
| Mar 2018 | - | $5.14 M(+10.3%) |
| Dec 2017 | - | $4.66 M(-9.4%) |
| Sep 2017 | - | $5.14 M(+19.1%) |
| Jun 2017 | $20.66 M(+30.7%) | $4.32 M(-20.4%) |
| Mar 2017 | - | $5.43 M(+22.2%) |
| Dec 2016 | - | $4.44 M(-31.4%) |
| Sep 2016 | - | $6.47 M(+1.1%) |
| Jun 2016 | $15.81 M(+102.5%) | $6.40 M(+80.1%) |
| Mar 2016 | - | $3.56 M(+9.8%) |
| Dec 2015 | - | $3.24 M(+23.9%) |
| Sep 2015 | - | $2.61 M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | $7.81 M(>+9900.0%) | $2.24 M(+22.7%) |
| Mar 2015 | - | $1.83 M(>+9900.0%) |
| Feb 2015 | - | $9400.00(-38.6%) |
| Nov 2014 | - | $15.30 K(+41.7%) |
| Aug 2014 | $58.50 K(-99.1%) | $10.80 K(-10.7%) |
| Jun 2014 | $6.41 M(>+9900.0%) | - |
| May 2014 | - | $12.10 K(-41.3%) |
| Feb 2014 | - | $20.60 K(+37.3%) |
| Nov 2013 | - | $15.00 K(+64.8%) |
| Aug 2013 | $54.20 K(-6.7%) | $9100.00(-33.6%) |
| May 2013 | - | $13.70 K(+8.7%) |
| Feb 2013 | - | $12.60 K(-33.0%) |
| Nov 2012 | - | $18.80 K(-0.5%) |
| Aug 2012 | $58.10 K(-56.5%) | $18.90 K(+70.3%) |
| May 2012 | - | $11.10 K(+20.7%) |
| Feb 2012 | - | $9200.00(-51.3%) |
| Nov 2011 | - | $18.90 K(-73.3%) |
| Aug 2011 | $133.60 K(+135.6%) | $70.70 K(+253.5%) |
| May 2011 | - | $20.00 K(-24.0%) |
| Feb 2011 | - | $26.30 K(+58.4%) |
| Nov 2010 | - | $16.60 K(+26.7%) |
| Aug 2010 | $56.70 K(-1.6%) | $13.10 K(-5.1%) |
| May 2010 | - | $13.80 K(+22.1%) |
| Feb 2010 | - | $11.30 K(-38.9%) |
| Nov 2009 | - | $18.50 K(+77.9%) |
| Aug 2009 | $57.60 K(+4.7%) | $10.40 K(-1.0%) |
| May 2009 | - | $10.50 K(-30.5%) |
| Feb 2009 | - | $15.10 K(-29.8%) |
| Nov 2008 | - | $21.50 K(+82.2%) |
| Aug 2008 | $55.00 K(+17.3%) | $11.80 K(-31.8%) |
| May 2008 | - | $17.30 K(+63.2%) |
| Feb 2008 | - | $10.60 K(-30.3%) |
| Nov 2007 | - | $15.20 K(+35.7%) |
| Aug 2007 | $46.90 K | $11.20 K(-18.2%) |
| May 2007 | - | $13.70 K(-8.7%) |
| Feb 2007 | - | $15.00 K(+114.3%) |
| Nov 2006 | - | $7000.00(+268.4%) |
| May 2006 | - | $1900.00 |
FAQ
- What is Aytu BioPharma annual total operating expenses?
- What is the all time high annual operating expenses for Aytu BioPharma?
- What is Aytu BioPharma annual operating expenses year-on-year change?
- What is Aytu BioPharma quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aytu BioPharma?
- What is Aytu BioPharma quarterly operating expenses year-on-year change?
What is Aytu BioPharma annual total operating expenses?
The current annual operating expenses of AYTU is $57.48 M
What is the all time high annual operating expenses for Aytu BioPharma?
Aytu BioPharma all-time high annual total operating expenses is $88.39 M
What is Aytu BioPharma annual operating expenses year-on-year change?
Over the past year, AYTU annual total operating expenses has changed by -$21.49 M (-27.21%)
What is Aytu BioPharma quarterly total operating expenses?
The current quarterly operating expenses of AYTU is $12.13 M
What is the all time high quarterly operating expenses for Aytu BioPharma?
Aytu BioPharma all-time high quarterly total operating expenses is $26.75 M
What is Aytu BioPharma quarterly operating expenses year-on-year change?
Over the past year, AYTU quarterly total operating expenses has changed by -$1.77 M (-12.76%)